The director of the pediatric gender clinic at Boston Children’s Hospital admitted that puberty blockers cause infertility and are given out to children “like candy” to a “skyrocketing” number of new patients in a recently uncovered video conference.
Dr. Jeremi Carswell, pediatric endocrinologist and current director of Boston Children’s Hospital GeMS (Gender Management Service), spoke of the permanent loss of fertility and unregulated frequency at which puberty-blocking drugs are administered to children at a 2020 Advancing Excellence in Transgender Health (AETH) conference, according to a recorded webinar called “Puberty Blockers and Hormone Therapy for Gender Diverse Youth and Adolescents” on the National LGBTQIA+ Health Education Center website.
“This is probably no surprise to everybody who is listening: the number of adolescents who have been coming into gender programs over the last several years has really kind of skyrocketed,” began Carswell. “This is a worldwide phenomenon and we’re not really quite sure what the story is behind that, but we do know that a lot of people have been presenting [with gender dysphoria], mostly assigned females.”
In the following slide, Carswell shows a graph displaying “new patient volume by year” at the GeMs clinic, showing a sharp increase in the number of patients it sees.
“I ended it at 2017 because we’ve pretty much maxed out on our capacity to see patients,” said Carswell. “It’s pretty much the same for 2018 and 2019 as far as I know. For 2020, we did a little bit of rearranging about how we did things, so I expect that number to go higher.”
“Our admin staff is telling me on an average week, we get anywhere from two to about eighteen calls for new patients per week,” Carswell added.
Carswell begins by referring to puberty blocking drugs as a “reversible therapy,” but then goes on to discuss the “risks/consequences” of prescribing them to children at the first signs of puberty to stop the development of secondary sex characteristics. Children who begin taking puberty blockers during the first signs of puberty and go on to take cross-sex hormones, which constitutes the vast majority, will become sterilized and may never be able to achieve orgasm, as Carswell explained:
If you are giving something that shuts down your estrogen or shuts down testosterone entirely, you’re going to stop either — if you had already been producing sperm or eggs, you’re going to stop doing that — and if you never started, you’re not going to be able to advance the gonads to be able to do that.
Additionally, puberty blockers stunt development of the male genitalia and have been shown to have serious side effects, which include a decline in bone density, neurological effects, and psychiatric problems. Doctors have prescribed puberty blockers off-label as a “treatment” for gender dysphoria on an experimental basis. There are no long-term studies to support its use in this context and they are not FDA approved for their off-label use.
The FDA recently issued a warning for puberty-blocking drugs after identifying a serious potential side effect that may cause a dangerous surge of spinal fluid pressure in the brain for some children. This build-up can cause headaches, nausea, double vision, and even permanent vision loss.
During a question and answer segment during Carswell’s presentation, Carswell was asked if she believes if puberty blockers could safely be administered by primary care providers.
“I think, you know, like I said, there’s a lot of people using blockers, and that’s great because it can be really helpful, but I think, um, I worry that they’re being given out a lot like candy, which is great in some ways, but it’s also like ok well, you know, you need to have the conversation about fertility,” Carswell said. “And you need to understand that you don’t get to have this like Peter Pan life.”
In the same presentation, Carswell suggested that some doctors let their young patients dictate the terms of their sex change.
“I’ve never seen anywhere in medicine as much as I do in this field where I think we as providers get very, very, very swayed by our patients, and um, I think that’s dangerous,” said Carswell. “We don’t need a generation of people who are having all these health issues because we didn’t want to wait and be a little more cautious with our treatments.”
Reuters published data on the rising number of children and adolescents adopting a transgender identity and seeking medical interventions. Among the shocking revelations is that between 2017 to 2021, 17,683 of the 121,882 children ages 6 to 17 diagnosed with gender dysphoria received puberty blockers or cross-sex hormones. Reuters said these numbers were a “significant undercount” since they don’t include children whose records did not specify a gender dysphoria diagnosis or whose treatment wasn’t covered by insurance.
In a now deleted video on the Boston Children’s YouTube channel, Carswell said that some children know that they are transgender from “the minute they were born.”
Breitbart News reported that Carswell has received financial compensation from Endo Pharmaceuticals, the manufacturer of a puberty-blocking drug.